Cargando…

Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan

BACKGROUND: To prevent antimicrobial resistance, both antimicrobial stewardship (AMS) and antifungal stewardship (AFS) in inpatient settings are needed in small/middle-sized hospitals as well as large hospitals. METHODS: We conducted the web-based, self-administered, nationwide cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moriyama , Yuki, Ishikane, Masahiro, Kusama, Yoshiki, Matsunaga, Nobuaki, Tajima, Taichi, Hayakawa, Kayoko, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050890/ https://www.ncbi.nlm.nih.gov/pubmed/33858346 http://dx.doi.org/10.1186/s12879-021-06035-5

Ejemplares similares

2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan
por: Moriyama, Yuki, et al.
Publicado: (2019)

Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections
por: Muraki, Yuichi, et al.
Publicado: (2020)

Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings
por: Kusama, Yoshiki, et al.
Publicado: (2020)

Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan—The Impact of Postprescription Review and Feedback
por: Akazawa, Tsubasa, et al.
Publicado: (2019)

1785. Regional Variation of Antimicrobial Use in Japan From 2013 to 2016
por: Kusama, Yoshiki, et al.
Publicado: (2018)

Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan
por: Jindai, Kazuaki, et al.
Publicado: (2020)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
por: Saito, Sho, et al.
Publicado: (2018)

Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012–2017
por: Kimura, Yuki, et al.
Publicado: (2019)

Cost of inappropriate antimicrobial use for upper respiratory infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

2201. Cost of Antimicrobial Use Against Upper Respiratory Infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2019)

Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
por: Goto, Ryota, et al.
Publicado: (2022)

908. Evaluation of Blood Culture Submission Rates in Japan
por: Tajima, Taichi, et al.
Publicado: (2020)

2184. Surveillance System of Healthcare-Associated Infection in High and Upper-Middle Income Countries: A Scoping Review
por: Takaya, Saho, et al.
Publicado: (2018)

1454. Cephalosporins and Quinolones Account for 95 Percent of Oral Antibiotic Treatment for Uncomplicated Cystitis in Japan
por: Kusama, Yoshiki, et al.
Publicado: (2019)

Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
por: Ono, Akane, et al.
Publicado: (2022)

National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational study
por: Kusama, Yoshiki, et al.
Publicado: (2021)

2017. Age-specific Distribution of Antimicrobial Days of Therapy (DOT) Using National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB Japan): Comparison with Defined Daily Doses per 1,000 Inhabitants Per Day (DID)
por: Yamasaki, Daisuke, et al.
Publicado: (2019)

The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years
por: Ishikane, Masahiro, et al.
Publicado: (2019)

223. Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
por: Endo, Mio, et al.
Publicado: (2020)

Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia
por: Ishikane, Masahiro, et al.
Publicado: (2016)

The role of antifungal stewardship
Publicado: (2020)

2021. Comparison of Patterns of National Oral Antibiotic Use Between All Dentists and Medical Doctors in Japan in 2016 Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)
por: Ishikane, Masahiro, et al.
Publicado: (2019)

The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan
por: Ono, Akane, et al.
Publicado: (2020)

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan
por: Hara, Hisao, et al.
Publicado: (2021)

773. First National Survey of Antibiotic Use Prescribed by All Dentists in Japan from 2015 to 2017 using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)
por: Ishikane, Masahiro, et al.
Publicado: (2019)

Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

Effects of population age structure on parenteral antimicrobial use estimations
por: Koizumi, Ryuji, et al.
Publicado: (2023)

Characteristics and limitations of national antimicrobial surveillance according to sales and claims data
por: Kusama, Yoshiki, et al.
Publicado: (2021)

Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013–2018
por: Ide, Satoshi, et al.
Publicado: (2023)

Antifungal stewardship in solid organ transplantation
por: Kriegl, Lisa, et al.
Publicado: (2022)

Antifungal stewardship in critically ill patients
por: De Pascale, Gennaro, et al.
Publicado: (2023)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

158. National Cross-Sectional Study of Factors Influencing the Decision of Prescribing Penicillin as First Choice among Dentists in Japan
por: Koizumi, Ryuji, et al.
Publicado: (2021)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021)

Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

The Current State of Antifungal Stewardship in Immunocompromised Populations
por: Alegria, William, et al.
Publicado: (2021)

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

Stewardship applied to antipsychotics: Development of an antipsychotic stewardship program in inpatient settings for monitoring and optimizing outcomes
por: Gonzales, Gillian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3hn66cl1du5dfhlm5rthrpprm4